Insulin (Oramed Pharmaceuticals)

N/A

Report date: 2026/05/09 20:00:18

Base Information

Drug NameInsulin (Oramed Pharmaceuticals)
Drug Alias NameOrally ingestible insulin capsule - Oramed PharmaceuticalsORMD 0801ORMD-0801
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes Mellitus +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesIsrael +[4] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesOramed Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesOramed LtdOraTech Pharmaceuticals IncHefei Tianhui Incubator of Technologies Co Ltd +[8] 
Inactive CompaniesUT Health San Antonio
Active IndicationsDiabetes Mellitus, Type 2Diabetes MellitusMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsDiabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A